PERSPECTA

News from every angle

← Back to headlines

Candel Therapeutics Reports Q4 GAAP EPS of -$0.54

Candel Therapeutics announced its GAAP EPS for the fourth quarter was -$0.54.

12 Mar, 19:02 — 12 Mar, 19:02
PostShare

Sources

Showing 1 of 1 sources
seeking-alphaMixed2h ago

Candel Therapeutics GAAP EPS of -$0.54

Read full article →

Related Stories

Atlanticus Holdings Reports Strong Q4 Earnings and Revenue Beat

25m ago

United Maritime Reports Q4 Non-GAAP EPS of -$0.17, Revenue of $6.6M

26m ago

Mach Natural Resources LP Reports Q4 Results

27m ago

Mineralys Therapeutics Reports Q4 GAAP EPS Beat

27m ago